Bicycle Therapeutics plc BCYC

$ 19.97 -1.92%

Quarterly report 2024-Q3
added 10-31-2024

Bicycle Therapeutics plc Balance Sheet 2011-2024 | BCYC

Annual Balance Sheet Bicycle Therapeutics plc

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-491 M	-306 M	-406 M	-121 M	-90.2 M	-63.4 M	-67.7 M	-	-	-	-	-	-
Long Term Debt	30.7 M	30.3 M	29.9 M	14.5 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	4.88 M	3.12 M	2.38 M	844 K	640 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	8.18 M	143 M	112 M	-	-	-	-	-	-
Total Current Liabilities	69.5 M	53.3 M	36.2 M	23.1 M	8.82 M	-	-	-	-	-	-	-	-
Total Liabilities	224 M	140 M	134 M	65.7 M	17 M	151 M	121 M	-	-	-	-	-	-
Deferred Revenue	25 M	20.4 M	19.3 M	10.1 M	728 K	10 K	3.98 M	-	-	-	-	-	-
Retained Earnings	-512 M	-331 M	-218 M	-152 M	-101 M	-69.9 M	-48.1 M	-	-	-	-	-	-
Total Assets	595 M	411 M	480 M	161 M	110 M	81.6 M	74 M	-	-	-	-	-	-
Cash and Cash Equivalents	526 M	339 M	439 M	136 M	-	63.4 M	67.7 M	-	-	-	-	-	-
Book Value	371 M	271 M	346 M	95.5 M	93.2 M	-69.8 M	-47.2 M	-	-	-	-	-	-
Total Shareholders Equity	371 M	271 M	346 M	95.5 M	93.2 M	-69.8 M	-47.2 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Bicycle Therapeutics plc

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	920 K	8.5 M	30.8 M	30.7 M	30.6 M	30.5 M	30.4 M	30.3 M	30.2 M	-	30 M	29.9 M	29.8 M	29.6 M	29.5 M	14.5 M	14.5 M	14.5 M	14.5 M	1.25 M	1.25 M	1.25 M	1.25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	166 M	184 M	191 M	224 M	223 M	234 M	186 M	140 M	128 M	-	129 M	134 M	111 M	84 M	81.8 M	65.7 M	65.7 M	65.7 M	65.7 M	17 M	17 M	17 M	17 M	29.3 M	29.3 M	29.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	11.4 M	11.6 M	16.4 M	25 M	27.2 M	29.8 M	25 M	20.4 M	16.4 M	-	19.2 M	19.3 M	17.5 M	8.74 M	10.1 M	10.1 M	10.1 M	10.1 M	10.1 M	728 K	728 K	728 K	728 K	10 K	10 K	10 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-629 M	-578 M	-538 M	-512 M	-463 M	-413 M	-370 M	-331 M	-301 M	-	-246 M	-218 M	-200 M	-186 M	-168 M	-152 M	-152 M	-152 M	-152 M	-101 M	-101 M	-101 M	-101 M	-69.9 M	-69.9 M	-69.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	997 M	1.06 B	547 M	595 M	639 M	454 M	429 M	411 M	417 M	-	460 M	480 M	281 M	226 M	224 M	161 M	161 M	161 M	161 M	110 M	110 M	110 M	110 M	81.6 M	81.6 M	81.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	891 M	961 M	457 M	526 M	572 M	340 M	294 M	339 M	361 M	373 M	407 M	439 M	260 M	199 M	196 M	-	-	-	-	-	-	-	-	-	63.4 M	63.4 M	-	67.7 M	-	-	-	9.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	831 M	874 M	356 M	371 M	416 M	220 M	243 M	271 M	289 M	-	330 M	346 M	171 M	142 M	142 M	95.5 M	95.5 M	95.5 M	95.5 M	93.2 M	93.2 M	93.2 M	93.2 M	52.4 M	52.4 M	52.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	831 M	874 M	356 M	371 M	416 M	220 M	243 M	271 M	289 M	311 M	330 M	346 M	171 M	142 M	142 M	95.5 M	95.5 M	95.5 M	95.5 M	93.2 M	93.2 M	93.2 M	93.2 M	-69.8 M	-69.8 M	-69.8 M	-47.7 M	-47.2 M	-	-	-	-33.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency